Stock Analiz

Pfizer Inc. (PFE) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Pfizer’s revenue went from $52.8B in fiscal 2016 to $62.6B in fiscal 2025, growth of about 1.9% a year.

Net income in fiscal 2025 was $7.8B, a net margin of 12.4%; the best year in this period was 2022 with $31.4B.

Over the twelve months to September 27, 2026, revenue was $63.6B and net income $4.0B.

Free cash flow was $9.1B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 7% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $52.8B162017: $52.5B172018: $40.8B182019: $40.9B192020: $41.7B202021: $81.3B212022: $101.2B222023: $59.6B232024: $63.6B242025: $62.6B25$62.6B
Net income
2016: $7.2B162017: $21.3B172018: $11.2B182019: $16.0B192020: $9.2B202021: $22.0B212022: $31.4B222023: $2.1B232024: $8.0B242025: $7.8B25$7.8B
Free cash flow
2016: $14.4B162017: $14.8B172018: $13.8B182019: $10.5B192020: $12.2B202021: $29.9B212022: $26.0B222023: $4.8B232024: $9.8B242025: $9.1B25$9.1B
EPS (diluted)
2016: $1.17162017: $3.52172018: $1.87182019: $2.82192020: $1.63202021: $3.85212022: $5.47222023: $0.37232024: $1.41242025: $1.3625$1.36

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$63.6B$62.6B$63.6B$59.6B$101.2B$81.3B$41.7B$40.9B$40.8B$52.5B$52.8B
Gross profit$46.7B$46.5B$45.8B$34.6B$66.8B$50.5B$33.2B$32.9B$31.8B$41.3B$40.5B
Operating income$7.0B$10.2B$11.1B$3.3B$36.0B$25.6B$8.5B$12.9B$4.9B$13.6B$9.5B
Net income$4.0B$7.8B$8.0B$2.1B$31.4B$22.0B$9.2B$16.0B$11.2B$21.3B$7.2B
EPS (diluted)$0.70$1.36$1.41$0.37$5.47$3.85$1.63$2.82$1.87$3.52$1.17
R&D$11.5B$10.4B$10.8B$10.7B$11.4B$10.4B$8.7B$8.4B$7.8B$7.7B$7.9B
Revenue growth—−1.7%+6.8%−41.1%+24.5%+95.2%+1.8%+0.2%−22.3%−0.5%+8.1%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$14.2B$11.7B$12.7B$8.7B$29.3B$32.6B$14.4B$12.6B$15.8B$16.8B$16.2B
Capital spending-$2.4B-$2.6B-$2.9B-$3.9B-$3.2B-$2.7B-$2.2B-$2.0B-$2.0B-$2.0B-$1.8B
Free cash flow$11.8B$9.1B$9.8B$4.8B$26.0B$29.9B$12.2B$10.5B$13.8B$14.8B$14.4B
Dividends paid$9.8B$9.8B$9.5B$9.2B$9.0B$8.7B$8.4B$8.0B$8.0B$7.7B$7.3B
Buybacks——$0$0$2.0B$0$0$8.9B$12.2B$5.0B$5.0B
Stock-based pay$1.1B$799M$877M$525M$872M$1.2B$755M$687M$923M$840M$691M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$10.3B$11.9B$7.3B$19.2B$24.0B$11.5B$9.6B$18.8B$20.0B$17.9B
Debt—$67.3B$63.8B$66.9B$38.7B$40.8B$40.6B$38.7B$37.7B$37.1B$35.6B
Equity—$86.5B$88.2B$89.0B$95.7B$77.2B$63.2B$63.1B$63.4B$71.3B$59.5B
Total assets—$208.2B$213.4B$226.5B$197.2B$181.5B$154.2B$167.6B$159.4B$171.8B$171.6B
Shares (diluted)5.75B5.71B5.70B5.71B5.73B5.71B5.63B5.67B5.98B6.06B6.16B

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin73.4%74.3%71.9%58.1%66.0%62.1%79.6%80.3%78.0%78.6%76.7%
Operating margin11.0%16.3%17.5%5.5%35.5%31.5%20.4%31.5%12.0%25.8%18.1%
Net margin6.3%12.4%12.6%3.6%31.0%27.0%22.0%39.2%27.3%40.6%13.7%
FCF margin18.5%14.5%15.5%8.1%25.7%36.7%29.2%25.8%33.9%28.2%27.2%
ROIC—5.2%5.8%1.7%24.2%20.1%7.7%12.0%3.8%9.9%8.7%
ROE—9.0%9.1%2.4%32.8%28.5%14.5%25.4%17.6%29.9%12.1%

Frequently asked questions

What is Pfizer’s annual revenue?

$62.6B in fiscal 2025 and $63.6B over the twelve months to September 27, 2026.

How much profit does Pfizer make?

Net income was $7.8B in fiscal 2025 (net margin 12.4%).

Is Pfizer’s revenue growing?

No: revenue fell 1.6% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.